Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LINE Lineage

交易中 08-27 14:28:41 EDT

39.85

-0.71

-1.75%

最高40.87	最低39.72	成交量28.10万
今开40.22	昨收40.56	日振幅2.82%
总市值90.49亿	流通市值22.79亿	总股本2.27亿
成交额1,125万	换手率0.49%	流通股本5,719万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":39.85,"timestamp":1787855317514,"preClose":40.56,"halted":0,"volume":280952,"delay":0,"changeRate":-0.017504930966469448,"floatShares":57192700,"shares":227080326,"eps":-0.72,"marketStatus":"交易中","change":-0.71,"latestTime":"08-27 14:28:41 EDT","open":40.22,"high":40.865,"low":39.72,"amount":11252423.161504,"amplitude":0.02823,"askPrice":39.87,"askSize":326,"bidPrice":39.84,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-0.72,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787860800000},"marketStatusCode":2,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":40.56,"dividendRate":0.053232,"preHourTrading":{"tag":"盘前","latestPrice":40.08,"preClose":40.56,"latestTime":"09:27 EDT","volume":344,"amount":13867.5,"timestamp":1787837260045,"change":-0.48,"changeRate":-0.011834,"amplitude":0.023176},"postHourTrading":{"tag":"盘后","latestPrice":40.56,"preClose":40.56,"latestTime":"19:30 EDT","volume":85926,"amount":3485158.08,"timestamp":1787787001744,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.635407,"impliedVol":0.4548,"impliedVolPercentile":0.4741},"requestUrl":"/m/hq/s/LINE/wiki","defaultTab":"wiki","newsList":[{"id":"2662767548","title":"中集来福士SMYRIL LINE RORO项目首艘船顺利交付","url":"https://stock-news.laohu8.com/highlight/detail?id=2662767548","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662767548?lang=zh_cn&edition=full","pubTime":"2026-08-26 13:28","pubTimestamp":1787722123,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4224","RORO","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657959765","title":"KAKAO GAMES CEO称无与LINE GAMES合并计划。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657959765","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657959765?lang=zh_cn&edition=full","pubTime":"2026-08-05 08:34","pubTimestamp":1785890062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LINE","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140335088","title":"财报前瞻｜Lineage本季度营收预计减少1.25%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1140335088","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140335088?lang=zh_cn&edition=full","pubTime":"2026-04-29 11:57","pubTimestamp":1777435066,"startTime":"0","endTime":"0","summary":"Lineage将于2026年05月06日发布财报，市场聚焦盈利质量与分红可持续性。上季度Lineage营收13.36亿美元，同比下降0.22%；毛利率32.26%；归属于母公司股东的净利润为600.00万美元，净利率0.45%；调整后每股收益为0.09美元，同比上升127.27%。上一季度公司毛利率为32.26%，在费用侧保持稳健，若本季度在客户结构与定价上继续偏向长期合约与高附加值存储，毛利率有望保持相对稳定。从近期机构研判与目标价调整看，市场观点偏多的声音占优。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Lineage本季度营收预计减少1.25%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132096461","title":"Lineage公司宣布首席信息官与首席转型官退休及过渡计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1132096461","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132096461?lang=zh_cn&edition=full","pubTime":"2026-04-09 20:16","pubTimestamp":1775736973,"startTime":"0","endTime":"0","summary":"Lineage公司近日公布了一项重要人事变动计划，公司首席信息官与首席转型官即将退休，相关职务交接方案已正式启动。此次高管层的平稳过渡，体现了公司治理结构的成熟与连续性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4224","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618390361","title":"IXCells达成iPSC细胞系交付里程碑IXCells Reaches iPSC Line Delivery Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2618390361","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618390361?lang=zh_cn&edition=full","pubTime":"2026-03-12 13:51","pubTimestamp":1773294660,"startTime":"0","endTime":"0","summary":"此次合作利用了iXCells的iPSCore平台，该平台能够大规模生成经过充分鉴定的患者来源iPSC细胞系，以支持新型疗法的发现与开发。The platform supports drug discovery by enabling the creation, characterization and delivery of validated iPSC lines derived from diverse patient cohorts. iPSCore is delivering nearly 200 lines per month, with a reprogramming success rate exceeding 98%, and built-in cell banking at each stage to ensure continuity and mitigate risk.该平台通过支持创建、表征和交付源自不同患者群体的经过验证的iPSC细胞系来助力药物发现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031213531597aee702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031213531597aee702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618611853","title":"Lineage Cell Therapeutics, Inc.2025财年实现净利润-63.53百万美元，同比减少241.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618611853","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618611853?lang=zh_cn&edition=full","pubTime":"2026-03-09 00:01","pubTimestamp":1772985680,"startTime":"0","endTime":"0","summary":"3月9日，Lineage Cell Therapeutics, Inc.公布财报，公告显示公司2025财年净利润为-63.53百万美元，同比减少241.38%；其中营业收入为14.56百万美元，同比增加53.26%，每股基本收益为-0.28美元。从资产负债表来看，Lineage Cell Therapeutics, Inc.总负债69.24百万美元，其中短期债务853000.00美元，资产负债比为0.02，流动比率为5.21。机构评级：截至2026年3月9日，当前有5家机构对Lineage Cell Therapeutics, Inc.目标价做出预测，其中目标均价为4.60美元，其中最低目标价为3.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000152a4587951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000152a4587951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617583816","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.43%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617583816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617583816?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:31","pubTimestamp":1772807502,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日22时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.43%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，Day One Biopharmaceuticals, Inc.、Solid Biosciences Inc.、Moolec Science Sa C/Wts 30/01/2028涨幅较大，Day One Biopharmaceuticals, Inc.、Quince Therapeutics, Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为26.07%、19.67%、16.48%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Contineum Therapeutics, Inc.、Cartesian Therapeutics, Inc.，振幅分别为24.36%、9.30%、7.69%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306223142954392bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306223142954392bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4224","LCTX","BK4007","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166565406","title":"Lineage Cell Therapeutics 2024年第四季度GAAP每股收益$(0.02) 超过预期$(0.03)，销售额$2.900百万 超预期$1.621百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1166565406","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166565406?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:08","pubTimestamp":1741637306,"startTime":"0","endTime":"0","summary":"公司报告季度销售额$2.900百万，超过了分析师共识预估的$1.621百万，提高了78.88%。与去年同期的销售额$2.100百万相比，这一数字增长了38.10%。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$ Cell $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 33.33 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $2.900 million which beat the analyst consensus estimate of $1.621 million by 78.88 percent.  This is a 38.10 percent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LINE","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220660","title":"Scotiabank：维持Lineage(LINE.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至74.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220660","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518220660?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:02","pubTimestamp":1741629758,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Lineage(LINE.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至74.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11020248641749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518527621","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速上涨7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518527621?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:39","pubTimestamp":1741613947,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨7.06%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为487.59%、74.68%、56.14%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为34.57%、28.59%、25.35%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LINE","LENZ","BK4224","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517160017","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.53%报0.548美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517160017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517160017?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:51","pubTimestamp":1741279881,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.53%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4224","LINE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517028306","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517028306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517028306?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:32","pubTimestamp":1741109577,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时32分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ","BK4139","BK4224","LCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516344637","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.24%报0.532美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516344637?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:05","pubTimestamp":1741014302,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1039.63%、125.32%、100.95%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","BK4139","LINE","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514833037","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌7.13%报0.582美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514833037?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:48","pubTimestamp":1740689324,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时48分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速跳水7.13%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1949.46%、414.29%、197.51%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ","BK4224","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123042009","title":"异动解读 | 机构下调目标价,Lineage股价盘中大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123042009","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123042009?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:46","pubTimestamp":1740682013,"startTime":"0","endTime":"0","summary":"Lineage(LINE.US)今日盘中股价出现大幅波动,最高上涨5.21%。引起市场关注的原因是,分析机构Piper Sandler对该公司的投资评级进行了调整。\n\nPiper Sandler维持了Lineage的\"增持\"评级,但将目标价从90美元大幅下调至75美元。股价波动可能与市场对该调整的反应有关。\n\nLineage是一家房地产投资信托公司,为客户提供端到端的供应链服务,包括冷藏仓储、运输代理等。机构调低目标价或许意味着对该公司前景的担忧,但仍维持增持评级,也说明该公司未来仍有较大增长空间。具体原因有待进一步观察和分析。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 机构下调目标价,Lineage股价盘中大涨5.21%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514336753","title":"Lineage, Inc.盘中异动 快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514336753?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:40","pubTimestamp":1740681645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时40分，Lineage, Inc.股票出现波动，股价急速上涨5.16%。Lineage, Inc.股票所在的房地产信托行业中，整体涨幅为0.52%。其相关个股中，Generation Income Properties Inc C/Wts 、Medical Properties Trust, Inc.、Postal Realty Trust, Inc.涨幅较大，Wheeler Real Estate Investment Trust, Inc.、Orchid Island Capital, Inc.、Medical Properties Trust, Inc.较为活跃，换手率分别为7.83%、2.84%、2.78%，振幅较大的相关个股有Generation Income Properties Inc C/Wts 、Service Properties Trust - Shares Of Beneficial Interest、Power Reit ，振幅分别为192.70%、17.29%、14.40%。Lineage, Inc.公司简介：Lineage Inc是一家房地产投资信托。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022802404598953ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022802404598953ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514836593","title":"Baird：维持Lineage(LINE.US)评级，由优于大市调整至优于大市评级, 目标价由76.00美元调整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514836593","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514836593?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:22","pubTimestamp":1740666171,"startTime":"0","endTime":"0","summary":"Baird：维持Lineage(LINE.US)评级，由优于大市调整至优于大市评级, 目标价由76.00美元调整至70.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27222248438483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514526388","title":"Piper Sandler：维持Lineage(LINE.US)评级，由增持调整至增持评级, 目标价由90.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514526388","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514526388?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:06","pubTimestamp":1740665207,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Lineage(LINE.US)评级，由增持调整至增持评级, 目标价由90.00美元调整至75.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27220648438141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108635388","title":"Lineage 第四季度 GAAP 每股盈余 $(0.33) 未达 $0.09 预期，销售额 $13.4 亿持平","url":"https://stock-news.laohu8.com/highlight/detail?id=1108635388","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108635388?lang=zh_cn&edition=full","pubTime":"2025-02-26 19:31","pubTimestamp":1740569516,"startTime":"0","endTime":"0","summary":"Lineage  公布季度亏损每股 $，未达到分析师普遍预期的 $0.09，差了 466.67%。这是相较于去年同期每股 $ 的亏损增长了 23.26%。公司报告季度销售额为 $13.4 亿，符合分析师普遍预期。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $0.09 by 466.67 percent. This is a 23.26 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $1.34 billion which met the analyst consensus estimate.  This is a 0.37 percent increase over sales of $1.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Lineage 第四季度 GAAP 每股盈余 $(0.33) 未达 $0.09 预期，销售额 $13.4 亿持平","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512651851","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512651851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512651851?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:41","pubTimestamp":1739889678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时41分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅拉升5.04%。截至发稿，该股报0.730美元/股，成交量20.4838万股，换手率0.09%，振幅3.25%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224118abd3b177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224118abd3b177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","BK4139","LENZ","LINE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onelineage.com;ir.onelineage.com","stockEarnings":[{"period":"1week","weight":-0.029},{"period":"1month","weight":-0.0468},{"period":"3month","weight":-0.0765},{"period":"6month","weight":0.001},{"period":"1year","weight":-0.0037},{"period":"ytd","weight":0.1589}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.1168},{"period":"1year","weight":0.1874},{"period":"ytd","weight":0.1234}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage, Inc.于2017年4月在马里兰州成立，是全球最大的温控仓储房地产投资信托基金（REIT）。公司拥有现代化且战略布局合理的物业网络，旨在为温控供应链中的多元化客户提供无缝衔接、技术赋能的客户体验。截至2025年12月31日，Lineage已建立起一个互联互通的全球仓储网络，涵盖501个仓库，总面积约8800万平方英尺，总容量达31亿立方英尺，主要分布在人口密集的配送中心市场。公司拥有稳定且多元化的客户群体，包括来自业内一些最大的食品零售商、制造商、加工商和食品服务分销商的11000多家客户。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.009942},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.051794},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.047075},{"month":4,"riseRate":0.909091,"avgChangeRate":0.072457},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.085175},{"month":6,"riseRate":0.7,"avgChangeRate":0.017118},{"month":7,"riseRate":0.6,"avgChangeRate":-0.034691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.040778},{"month":9,"riseRate":0.4,"avgChangeRate":-0.041279},{"month":10,"riseRate":0.7,"avgChangeRate":0.025106},{"month":11,"riseRate":0.4,"avgChangeRate":-0.07115},{"month":12,"riseRate":0.6,"avgChangeRate":-0.044918}],"exchange":"NASDAQ","name":"Lineage","nameEN":"Lineage"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage,LINE,Lineage股票,Lineage股票老虎,Lineage股票老虎国际,Lineage行情,Lineage股票行情,Lineage股价,Lineage股市,Lineage股票价格,Lineage股票交易,Lineage股票购买,Lineage股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}